retatrutide type 2 diabetes trial results 2024 phase 2 Retatrutide, a GIP, GLP-1 and glucagon receptor Retatrutide produces up to 30.3%
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



























